News & Updates

Neuroenzyme inhibition a possible analgesic for chronic pancreatitis

05 Jan 2021 by

Severe chronic pain in patients with inflammation of the pancreas could be relieved by inhibiting a specific neuroenzyme, according to a new study.

Neuroenzyme inhibition a possible analgesic for chronic pancreatitis

05 Jan 2021

Original New Drug Application Approvals by US FDA (16 - 31 December 2020)

05 Jan 2021

New drug applications approved by US FDA as of 16 - 31 December 2020 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 31 December 2020)

05 Jan 2021

Rilonacept beneficial to pericarditis patients

04 Jan 2021

In patients with recurrent pericarditis, rilonacept delivers fast and sustained pain relief, with parallel improvements in inflammation and health-related quality of life, according to a phase II open-label study.

Rilonacept beneficial to pericarditis patients

04 Jan 2021

Pregnancy stress may lead to sickly children

04 Jan 2021

Self-perceived stress during pregnancy exacerbates the risk of infectious and non-infectious disease in the offspring, a recent study has found.

Pregnancy stress may lead to sickly children

04 Jan 2021

Fluvoxamine may prevent clinical deterioration in COVID-19 outpatients

04 Jan 2021 by

In a fully remote, preliminary study evaluating adult outpatients with mild COVID-19, the likelihood of clinical deterioration* over 15 days was lower among those treated with fluvoxamine – an SSRI** and a strong σ-1 receptor (S1R) agonist – compared with those receiving placebo.

Fluvoxamine may prevent clinical deterioration in COVID-19 outpatients

04 Jan 2021

Parkinson’s disease ups risk of suicide

04 Jan 2021 by

Patients with Parkinson’s disease (PD) have a significantly increased risk of suicide compared with the general population, results of a population-based cohort study from Taiwan have shown.

Parkinson’s disease ups risk of suicide

04 Jan 2021

Early-onset GDM linked to adverse pregnancy outcomes

04 Jan 2021

Gestational diabetes mellitus (GDM) diagnosed early by oral glucose tolerance test (OGTT) at 18 to 20 gestational weeks predicts maternal and neonatal metabolic disorders as well as pregnancy outcomes, a study has found.

Early-onset GDM linked to adverse pregnancy outcomes

04 Jan 2021

T1D glucagon levels disrupted after a meal

04 Jan 2021

Glucagon levels are dysregulated following a meal among patients with type 1 diabetes (T1D), a new study reports. In turn, this may contribute to postprandial hyperglycaemia, independent of residual β-cell effects.

T1D glucagon levels disrupted after a meal

04 Jan 2021

Private-public partnership aims to make work commute safer by disinfecting high touch surfaces in public transports.

04 Jan 2021 by

The Ministry of Transport Malaysia and Gentle Supreme, a distributor of household products, have partnered to roll out the ‘Keep Malaysia Safe & Protected’ campaign.

Private-public partnership aims to make work commute safer by disinfecting high touch surfaces in public transports.

04 Jan 2021

Thiamine supplement hits mark in chronic fatigue trial

03 Jan 2021

High-dose thiamine supplementation is safe and helps alleviate chronic fatigue in patients with quiescent inflammatory bowel disease, as shown in a study.

Thiamine supplement hits mark in chronic fatigue trial

03 Jan 2021

News & Updates

Filter by Specialty:

Specialty:

Neuroenzyme inhibition a possible analgesic for chronic pancreatitis

Neuroenzyme inhibition a possible analgesic for chronic pancreatitis

Original New Drug Application Approvals by US FDA (16 - 31 December 2020)

Original New Drug Application Approvals by US FDA (16 - 31 December 2020)

Rilonacept beneficial to pericarditis patients

Rilonacept beneficial to pericarditis patients

Pregnancy stress may lead to sickly children

Pregnancy stress may lead to sickly children

Fluvoxamine may prevent clinical deterioration in COVID-19 outpatients

Fluvoxamine may prevent clinical deterioration in COVID-19 outpatients

Parkinson’s disease ups risk of suicide

Parkinson’s disease ups risk of suicide

Early-onset GDM linked to adverse pregnancy outcomes

Early-onset GDM linked to adverse pregnancy outcomes

T1D glucagon levels disrupted after a meal

T1D glucagon levels disrupted after a meal

Private-public partnership aims to make work commute safer by disinfecting high touch surfaces in public transports.

Private-public partnership aims to make work commute safer by disinfecting high touch surfaces in public transports.

Thiamine supplement hits mark in chronic fatigue trial

Thiamine supplement hits mark in chronic fatigue trial